Topics
Innovation
Laser
Medical
Practice
Research
Surgical
Training
View Issue
Sponsored by Quantel Medical
View Insert
Sponsored By Allergan, an AbbVie company
View Supplement
In This Issue
Iqbal Ike K. Ahmed, MD, FRCSC
Answers to top questions related to practice, patient, and staff safety.
Joshua F. Alloy, JD
The patient perspective on the changes made and updates still desired.
Richie Kahn, MPH
Clinicians discuss the diagnosis and therapeutic considerations.
Devesh K. Varma, MD, FRCSC; Reena A. Garg, MD; and Michael D. Greenwood, MD
Two studies examine how the field may grow as concern about costs increases.
Christopher C. Teng, MD, and Soshian Sarrafpour, MD
An overview of similarities and differences in systems far and wide.
Deli Krizova, FEBO; Pavel Kuchynka, CSc, FCMA; Wanjiku Mathenge, MBChB, MMed, MSc, PhD; Radhika Rampat, MBBS, BSc(Hons), FRCOphth; Andrew Scott, PhD, MD, FRCOphth, MRCSEd, FEBO; Jorge E. Valdez-GarcĂa, MD, PhD; and Riccardo Vinciguerra, MD
Insights into the use of these treatments as additive therapies for IOP reduction.
Vladislav P. Bekerman, MD, MBA, and Albert S. Khouri, MD
Providers must be aware of the common and uncommon side effects associated with each agent and class of medication.
Eileen Chang, MD; Soshian Sarrafpour, MD; and Christopher C. Teng, MD
A primer on Twitter for ophthalmologists.
Edmund Tsui, MD
Certain requirements can delay, limit, or prohibit patient access to advances in glaucoma care.
George R. Reiss, MD
What are the current applications of the outcomes of the Collaborative Initial Glaucoma Treatment Study?
Catherine Q. Sun, MD
What are the current applications of the outcomes of the Tube Versus Trabeculectomy study?
Lilian Nguyen, MD
What are the current applications of the outcomes of the Advanced Glaucoma Intervention Study?
Frank Chin, MD, and Eydie Miller-Ellis, MD
What are the next steps?
Richard K. Parrish II, MD; Lorraine M. Provencher, MD; and Gregory L. Skuta, MD
Subscribe
Stay up to date all on all things Glaucoma by signing up to receive our print publication or subscribe to our email alerts.